Thirty-three strains of Legionella spp., 29 of which were L. pneumophila, were tested for their susceptibilities to erythromycin (EM), rosaramicin, tylosin, mycinamicin I (Sch-27897), and mycinamicin II (Sch-27896). Testing was performed using an agar dilution method with two different types of media: buffered charcoal yeast extract medium supplemented with 0.1% a-ketoglutarate (BCYEa) and filter-sterilized yeast extract medium with 0.1% a-ketoglutarate (BYEa). The minimal inhibitory concentrations (MICs) of the drugs tested relative to the MICs of erythromycin were: rosaramicin, MIC 0.2 EM MIC; tylosin, MIC 2 EM MIC; mycinamicin I, MIC 0.5 EM MIC; and mycinamicin II, MIC EM MIC. Both types of media caused equivalent partial inactivation of the macrolides which was apparently due entirely to pH effect. MICs on BCYEa were one to five times more than those observed on BYEa; this may be due to poorer growth on BYEa.
The treatment of choice for Legionnaires disease and other Legionella sp. infections is erythromycin (10, 12, 20) . Mycinamicins are new macrolide antibiotics with antibacterial spectra similar to the spectrum of erythromycin (17) . The purpose of this study was to determine whether two of the mycinamicin compounds had in vitro activity against Legionella sp. similar to other macrolide antibiotics (4, 7, 13, 14, 18) . In addition, the effect of deletion of activated charcoal from the growth medium was determined, as it is known that charcoal yeast extract (CYE) medium inactivates many antimicrobial agents, including macrolides (4, 7, 14) . This laboratory currently uses a filter-sterilized yeast extract medium without charcoal to test for pigment production of Legionella sp. (15) . Since most recent clinical and environmental isolates of L. pneumophila grow readily on this medium, we felt that this medium could be used to grow Legionella sp. for susceptibility testing. Likewise, we felt that study of this charcoal-deleted medium could clarify whether charcoal was the interfering substance in CYE. Additional purposes were to study lower concentrations of rosaramicin than were previously tested (4) Four other species were also tested:
, and L. longbeachae (Los Angeles 24). These isolates of the other species were clinical isolates and all except one (Los Angeles 24) were obtained from the Centers for Disease Control. A total of 14 VAWMC isolates were passed on BCYEa medium between 10 and 20 times before testing. All of the isolates from Centers for Disease Control and Japan were passed multiple times on CYE or BCYEa medium. Staphylococcus aureus ATCC 25923 was tested at the same time as the Legionella strains.
All bacteria tested had been frozen at -70°C in skim milk for 1 to 24 months. They were thawed, subcultured twice on BCYEa medium, and portioned into multiple skim milk-containing freezer vials. They were then refrozen at -70°C. Before inoculation of the susceptibility testing plates, frozen samples of the organisms were thawed and passed twice (48-h incubation time) on BCYEa medium. This approach ensured that the test organisms were similar in each susceptibility run.
Inocula were prepared by harvesting growth from a 48 h plate with a sterile wooden stick into 1 ml of Mueller-Hinton broth. The turbidity of the suspension was adjusted to match that of the 0.5 MacFarland barium sulfate standard. The suspension was mixed with sterile glass beads in a Vortex blender. We have found that such a suspension of L. pneumophila yields 9 x 107 to 1 x 108 colony-forming units per ml; if glass beads are not used, the counts are more variable. The inoculum of S. aureus ATCC 25923 was prepared in a standard way (18) .
Plate inoculation. A Steer's replicator was used to inoculate the plates (18) . Assuming that the delivery volume is 0.001 ml, we plated -1.0 x 105 colonyforming units of the Legionella strains per inoculum spot. All plates were inoculated within 20 min of inoculum preparation, and duplicate plates were inoculated. Antibiotic-free plates were inoculated before and after inoculation of each set of organisms to detect contamination, antibiotic carry-over, or both.
Plate incubation and reading. Incubation was at 35°C in air with 80 to 85% relative humidity. Plates were read at 24 h for the S. aureus strain and 48 h for the Legionella strains. Less than 2 colony-forming units per spot was read as no growth, and haze was disregarded. If growth on the antibiotic-free plate was not confluent for a particular strain, results for that strain were not recorded.
Statistical analysis. (10) . These differences may be based on the complex interactions of respiratory tract tropism, alveolar macrophage concentration, and bacterial susceptibility to the drugs (2, 5, 8) .
Before the clinical efficacy of rosaramicin and the mycinamicins can be predicted, it is important that their abilities to be concentrated within the lung and the alveolar macrophage itself be studied. Likewise, the study of their efficacy in the treatment or prevention of infection in animal models of Legionella infection is needed (1, 6, 10) .
It is difficult to compare these results with those obtained by other investigators, because different media or methods, or both, were used. Also, with few exceptions, relatively few strains were studied by others. Regardless, our results for erythromycin MIC values are close to those found in other studies (4, 7, 13, 14, 18) .
As demonstrated in another study of L. pneumophila in vitro susceptibility patterns, there is considerable inhomogeneity which makes the interpretation of single strain susceptibility values hazardous (4). The statistically significant differences noted in this study represent relatively small absolute differences and are probably not clinically significant. However, the differences do seem to indicate that there are consistent differences between environmental (9) . It does seem unlikely that this new medium would be useful for susceptibility testing of macrolides, since the same pH differences would be obtained. Until an optimal susceptibility testing medium for Legionella spp. is developed, it is mandatory that all susceptibility studies report parallel testing of the antimicrobial agent on MHA with an S. aureus or E. coli control strain and that many Legionella strains are studied to detect heterogeneity.
